Atlas Trials

Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus

Clinical trial NCT07533591 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07533591
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease (PD)
Start date
2026-05-01
Primary completion
2029-04-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.